NJ State Employees Deferred Compensation Plan’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Hold |
91,600
| – | – | 0.39% | 54 |
|
|
2025
Q1 | $3.61M | Hold |
91,600
| – | – | 0.46% | 46 |
|
|
2024
Q4 | $2.76M | Hold |
91,600
| – | – | 0.34% | 66 |
|
|
2024
Q3 | $2.14M | Hold |
91,600
| – | – | 0.25% | 93 |
|
|
2024
Q2 | $1.63M | Hold |
91,600
| – | – | 0.2% | 109 |
|
|
2024
Q1 | $1.39M | Hold |
91,600
| – | – | 0.18% | 127 |
|
|
2023
Q4 | $1.56M | Hold |
91,600
| – | – | 0.22% | 105 |
|
|
2023
Q3 | $766K | Buy |
91,600
+19,000
| +26% | +$159K | 0.12% | 189 |
|
|
2023
Q2 | $1.8M | Hold |
72,600
| – | – | 0.26% | 89 |
|
|
2023
Q1 | $1.09M | Hold |
72,600
| – | – | 0.17% | 143 |
|
|
2022
Q4 | $859K | Hold |
72,600
| – | – | 0.14% | 169 |
|
|
2022
Q3 | $430K | Buy |
72,600
+45,600
| +169% | +$270K | 0.07% | 274 |
|
|
2022
Q2 | $115K | Hold |
27,000
| – | – | 0.02% | 450 |
|
|
2022
Q1 | $257K | Hold |
27,000
| – | – | 0.03% | 420 |
|
|
2021
Q4 | $513K | Hold |
27,000
| – | – | 0.06% | 295 |
|
|
2021
Q3 | $899K | Hold |
27,000
| – | – | 0.12% | 181 |
|
|
2021
Q2 | $1.05M | Hold |
27,000
| – | – | 0.14% | 159 |
|
|
2021
Q1 | $1.3M | Hold |
27,000
| – | – | 0.19% | 128 |
|
|
2020
Q4 | $1.41M | Hold |
27,000
| – | – | 0.22% | 108 |
|
|
2020
Q3 | $723K | Hold |
27,000
| – | – | 0.13% | 158 |
|
|
2020
Q2 | $526K | Hold |
27,000
| – | – | 0.1% | 204 |
|
|
2020
Q1 | $266K | Hold |
27,000
| – | – | 0.06% | 310 |
|
|
2019
Q4 | $300K | Hold |
27,000
| – | – | 0.05% | 397 |
|
|
2019
Q3 | $152K | Buy |
+27,000
| New | +$152K | 0.03% | 494 |
|